|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0019196,
umls-concept:C0205245,
umls-concept:C0205419,
umls-concept:C0229671,
umls-concept:C0239946,
umls-concept:C0332281,
umls-concept:C0439793,
umls-concept:C0441889,
umls-concept:C0524910,
umls-concept:C1413387,
umls-concept:C1954261
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-1-16
|
|
pubmed:abstractText |
YKL-40 is a chitinase-like protein involved in matrix remodelling and a non-invasive fibrosis marker. We assessed whether a functional promoter polymorphism in CHI3L1, encoding YKL-40, is associated with HCV-induced liver fibrosis and influences YKL-40 serum concentrations.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:BergThomasT,
pubmed-author:BerresMarie-LuiseML,
pubmed-author:HellerbrandClausC,
pubmed-author:MuellerTobiasT,
pubmed-author:PapenSvenS,
pubmed-author:PauelsKatrinK,
pubmed-author:SchmitzPetraP,
pubmed-author:TrautweinChristianC,
pubmed-author:WasmuthHermann EHE,
pubmed-author:WeiskirchenRalfR,
pubmed-author:ZaldivarMirko MorenoMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
370-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19070929-Adipokines,
pubmed-meshheading:19070929-Adult,
pubmed-meshheading:19070929-Female,
pubmed-meshheading:19070929-Glycoproteins,
pubmed-meshheading:19070929-Hepatitis C, Chronic,
pubmed-meshheading:19070929-Humans,
pubmed-meshheading:19070929-Lectins,
pubmed-meshheading:19070929-Liver Cirrhosis,
pubmed-meshheading:19070929-Male,
pubmed-meshheading:19070929-Middle Aged,
pubmed-meshheading:19070929-Polymorphism, Genetic,
pubmed-meshheading:19070929-Promoter Regions, Genetic,
pubmed-meshheading:19070929-RNA, Messenger
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
|
|
pubmed:affiliation |
Department of Internal Medicine III, University Hospital Aachen, RWTH Aachen, Pauwelsstr. 30, D-52057 Aachen, Germany.
|
|
pubmed:publicationType |
Journal Article
|
